Systematic Review Software Compared: Covidence, Rayyan, and DistillerSR

Dedicated systematic review software has become close to standard practice for managing screening, extraction, and collaboration across a review team, replacing older, more error-prone spreadsheet-based workflows. Covidence, Rayyan, and DistillerSR are the three most widely used platforms, and each has genuinely different strengths worth understanding before choosing one for your project.

Covidence: the most commonly recommended full-workflow option

Covidence supports the full review workflow -- deduplication, title and abstract screening, full-text screening, data extraction, and risk-of-bias assessment -- within a single integrated platform, with a genuinely intuitive interface that most new users learn quickly. It has strong institutional adoption, meaning many universities and health systems already have institutional licenses covering their researchers, and it integrates directly with Cochrane's review production workflow, making it a particularly natural choice for Cochrane-methodology reviews.

Rayyan: free, screening-focused, and widely accessible

Rayyan is free for individual use, which makes it an accessible entry point for students and researchers without institutional software budgets, and it focuses specifically and effectively on the screening stage, using a straightforward interface with a notable machine-learning-assisted feature that helps prioritize likely-relevant records earlier in the screening queue. It does not natively support the full extraction and risk-of-bias workflow the way Covidence does, meaning many teams use Rayyan specifically for screening and then move to a separate tool or structured spreadsheet for the remaining stages.

DistillerSR: built for larger, more complex reviews

DistillerSR is generally positioned toward larger-scale, more complex reviews, including systematic reviews conducted for health technology assessment and regulatory purposes, with more extensive customization options for building complex extraction forms and workflow rules. This flexibility comes with a steeper learning curve than Covidence or Rayyan, and it's often the choice for organizations running many concurrent, larger reviews rather than a single academic team running one review at a time.

Cost considerations

Rayyan's free tier is the most immediately accessible option for individual researchers or small student projects without institutional funding. Covidence requires either an institutional license, often already available through university library subscriptions worth checking before assuming you need to pay individually, or an individual paid subscription. DistillerSR is typically licensed at an organizational level and is generally the least accessible option for an individual researcher or small academic team working without institutional backing.

Screening features worth comparing directly

If dual independent screening with automatic conflict flagging matters most to your workflow, all three platforms support this core feature, though the specific interface for resolving conflicts differs meaningfully in ease of use between them. If machine-learning-assisted screening prioritization is important, particularly for reviews with a very large number of records to screen, Rayyan's implementation of this feature is generally considered strong and is available even in its free tier.

Extraction and appraisal features

Covidence's built-in extraction and risk-of-bias tools are generally considered more polished and easier to configure for standard systematic review workflows than building an equivalent process in Rayyan, which lacks native support for these later stages entirely. DistillerSR's extraction form builder offers the most extensive customization of the three, useful for reviews with unusually complex or non-standard data extraction needs.

Export and reporting compatibility

Whichever platform you choose, confirm it can export your screening and extraction data in a format compatible with your chosen statistical software for meta-analysis, and that it supports generating a PRISMA flow diagram directly or exporting the underlying numbers cleanly enough to build one elsewhere without manual re-counting.

A practical decision framework

For a single academic systematic review with a moderate number of records and standard methodology, Covidence, if institutionally available, is generally the most balanced choice across usability and full-workflow support. For a project without institutional software funding, or for a review needing only strong screening support with extraction handled separately, Rayyan is a genuinely capable and free starting point. For larger, more complex, or organizationally repeated review programs, DistillerSR's additional flexibility becomes more clearly worth its steeper learning curve and cost.

Software does not replace methodology

Whichever platform you choose, the software supports and organizes your process -- it does not substitute for the underlying methodological rigor of dual screening, a well-piloted extraction form, or a correctly matched risk-of-bias tool. A review conducted carelessly within excellent software still produces an unreliable result, and the choice of platform should be considered a genuine convenience and consistency aid, not a guarantee of methodological quality on its own.

Trial versions and switching platforms mid-review

Most paid platforms offer some form of trial access, and testing your actual workflow, not just browsing a features list, before committing your full review to one platform is worth the time investment, given how disruptive switching platforms partway through an active review can be. Migrating already-screened records between different systematic review software tools is rarely seamless, making the upfront platform choice more consequential than it might initially appear. Reading recent user reviews and, where possible, talking directly to a colleague who has completed a review using your shortlisted platform, adds a genuinely useful layer of real-world insight beyond a vendor's own marketing materials or feature comparison chart. Given how much of a systematic review's total working time gets spent inside whichever platform you choose, this upfront diligence in evaluating real-world fit against your team's actual specific workflow needs is time well spent relative to the many subsequent months you'll likely spend working within that chosen system. Treating this decision with the same seriousness you'd apply to any other significant methodological choice in your review, rather than picking whichever tool a colleague happened to mention first, reflects the same careful deliberation good systematic review practice expects everywhere else. The right software choice, made deliberately rather than by default, becomes an largely invisible enabler of good methodology rather than an obstacle your team has to work around for the length of an entire review project. A thoughtful choice made once, early, continues paying dividends quietly throughout every subsequent stage of the work that follows. Few upfront decisions in a systematic review offer this much lasting, compounding benefit.